Skip to main content
SpringerLink
Log in

Oesofaguscarcinoom

  • Chapter
  • First Online:
Ontwikkelingen in de oncologie

Part of the book series: Huisarts en Wetenschap ((HEW))

  • 1040 Accesses

Inleiding

Het oesofaguscarcinoom (figuur 24.1) is de op achtst na meest voorkomende en de op zes na dodelijkste kanker in de wereld. Histopathologisch onderscheidt men twee groepen oesofaguscarcinomen: adenocarcinomen en plaveiselcelcarcinomen . Algemeen wordt verondersteld dat adenocarcinomen zich ontwikkelen in een barrettoesofagus . Een barrettoesofagus ontstaat door metaplasie van plaveiselepitheel, dat onder invloed van gastro-oesofageale reflux transformeert tot intestinaal cilinderepitheel (figuur 24.2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatuur

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917.

    Article  Google Scholar 

  2. Van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ. Increasing incidence of Barrett’s oesophagus in the general population. Gut 2005;54:1062–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Post PN, Siersema PD, Van Dekken H. Rising incidence of clinically evident Barrett’s oesophagus in The Netherlands: A nation-wide registry of pathology reports. Scand J Gastroenterol 2007;42:17–22.

    Article  PubMed  Google Scholar 

  4. Coleman HG, Bhat S, Murray LJ, McManus D, Gavin AT, Johnston BT. Increasing incidence of Barrett’s oesophagus: a population-based study. Eur J Epidemiol 2011;26:739–45.

    Article  PubMed  Google Scholar 

  5. Sikkema M, Looman CW, Steyerberg EW, Kerkhof M, Kastelein F, Van Dekken H, et al. Predictors for neoplastic progression in patients with Barrett’s esophagus: a prospective cohort study. Am J Gastroenterol 2011;106:1231–8.

    Article  CAS  PubMed  Google Scholar 

  6. Desai TK, Krishnan K, Samala N, Singh J, Cluley J, Perla S, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut 2012;61:970–6.

    Article  PubMed  Google Scholar 

  7. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241–52.

    Article  CAS  PubMed  Google Scholar 

  8. Dikken JL, Lemmens VE, Wouters MW, Wijnhoven BP, Siersema PD, Nieuwenhuijzen GA, et al. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer 2012;48:1624–32.

    Article  PubMed  Google Scholar 

  9. Siersema P, Van Berge Henegouwen M, Bühre W, Dullemen HM, Van der Gaast A, Hage M, et al. Oesofaguscarcinoom: Landelijke richtlijn, Versie 3.0. Utrecht: Vereniging van Integrale Kankercentra, 2010. www.oncoline.nl/oesofaguscarcinoom, geraadpleegd juni 2013.

  10. Cao Y, Liao C, Tan A, Gao Y, Mo Z, Gao F. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 2009;41:751–7.

    Article  CAS  PubMed  Google Scholar 

  11. Soetikno R, Kaltenbach T, Yeh R, Gotoda T. Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol 2005;23:4490–8.

    Article  PubMed  Google Scholar 

  12. Fujishiro M, Yahagi N, Kakushima N, Kodashima S, Muraki Y, Ono S, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol 2006;4:688–94.

    Article  PubMed  Google Scholar 

  13. Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 2008;57:1200–6.

    Article  CAS  PubMed  Google Scholar 

  14. Akiyama J, Marcus SN, Triadafilopoulos G. Effective intra-esophageal acid control is associated with improved radiofrequency ablation outcomes in Barrett’s esophagus. Dig Dis Sci 2012;57:2625–32.

    Article  CAS  PubMed  Google Scholar 

  15. Krishnan K, Pandolfino JE, Kahrilas PJ, Keefer L, Boris L, Komanduri S. Increased risk for persistent intestinal metaplasia in patients with Barrett’s esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology 2012;143:576–81.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Konda VJ, Waxman I. Endotherapy for Barrett’s esophagus. Am J Gastroenterol 2012;107:827–33.

    Article  PubMed  Google Scholar 

  17. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 2009;360:2277–88.

    Article  CAS  PubMed  Google Scholar 

  18. Jin HL, Zhu H, Ling TS, Zhang HJ, Shi RH. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J Gastroenterol 2009;15:5983–91.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Boonstra JJ, Kok TC, Wijnhoven BP, Van Heijl M, Van Berge Henegouwen MI, Ten Kate FJ, et al. Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial. BMC Cancer 2011;11:181–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Van Hagen P, Hulshof MC, Van Lanschot JJ, Steyerberg EW, Van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012;366:2074–84.

    Article  CAS  PubMed  Google Scholar 

  21. Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, Van Dekken H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: Five-year survival of a randomized clinical trial. Ann Surg 2007;246:992–1000.

    Article  PubMed  Google Scholar 

  22. Hulscher JB, Van Sandick JW, De Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662–9.

    Article  PubMed  Google Scholar 

  23. Wang S, Liao Z, Chen Y, Chang JY, Jeter M, Guerrero T, et al. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience. J Thorac Oncol 2006;1:252–9.

    PubMed  Google Scholar 

  24. Tong DK, Law S, Kwong DL, Wei WI, Ng RW, Wong KH. Current management of cervical esophageal cancer. World J Surg 2011;35:600–7.

    Article  PubMed  Google Scholar 

  25. Verhage RJ, Hazebroek EJ, Boone J, Van Hillegersberg R. Minimally invasive surgery compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chir 2009;64:135–46.

    CAS  PubMed  Google Scholar 

  26. Butler N, Collins S, Memon B, Memon MA. Minimally invasive oesophagectomy: current status and future direction. Surg Endosc 2011;25:2071–83.

    Article  PubMed  Google Scholar 

  27. Biere SS, Van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicentre, open-label, randomised controlled trial. Lancet 2012;379:1887–92.

    Article  PubMed  Google Scholar 

  28. Watanabe M, Baba Y, Nagai Y, Baba H. Minimally invasive esophagectomy for esophageal cancer: an updated review. Surg Today 2012.

    Google Scholar 

  29. Dikken JL, van Sandick JW, Allum WH, Johansson J, Jensen LS, Putter H, et al. Differences in outcomes of oesophageal and gastric cancer surgery across Europe. Br J Surg 2013;100:83–94.

    Article  CAS  PubMed  Google Scholar 

  30. Van Vliet EP, Eijkemans MJ, Poley JW, Steyerberg EW, Kuipers EJ, Siersema PD. Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers. Gastrointest Endosc 2006;63:938–47.

    Article  PubMed  Google Scholar 

  31. Van Vliet EP, Hermans JJ, De Wever W, Eijkemans MJ, Steyerberg EW, Faasse C, et al. Radiologist experience and CT examination quality determine metastasis detection in patients with esophageal or gastric cardia cancer. Eur Radiol 2008;18:2475–84.

    Article  CAS  PubMed  Google Scholar 

  32. Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: Multicentre randomised trial. Lancet 2004;364:1497–504.

    Article  PubMed  Google Scholar 

  33. Bergquist H, Wenger U, Johnsson E, Nyman J, Ejnell H, Hammerlid E, et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus 2005;18:131–9.

    Article  CAS  PubMed  Google Scholar 

  34. De Wijkerslooth LR, Vleggaar FP, Siersema PD. Endoscopic management of difficult or recurrent esophageal strictures. Am J Gastroenterol 2011;106:2080-91; quiz 2092.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. afdeling Maag, Darm- en Leverziekten, Utrecht, Netherlands

    Christine Kestens

  2. afdeling Chirurgie, UMC, Utrecht, Netherlands

    Richard van Hillegersberg

  3. afdeling Maag, Darm- en Leverziekten, Utrecht, Netherlands

    Peter Siersema

Authors
  1. Christine Kestens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard van Hillegersberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Siersema
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cuijk, The Netherlands

    Linda Bröker

  2. NHG, Domus Medica, Utrecht, The Netherlands

    Just Eekhof

Copyright information

© 2014 Bohn Stafleu van Loghum

About this chapter

Cite this chapter

Kestens, C., van Hillegersberg, R., Siersema, P. (2014). Oesofaguscarcinoom. In: Bröker, L., Eekhof, J. (eds) Ontwikkelingen in de oncologie. Huisarts en Wetenschap. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-368-0436-3_24

Download citation

  • DOI: https://doi.org/10.1007/978-90-368-0436-3_24

  • Published:

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-368-0435-6

  • Online ISBN: 978-90-368-0436-3

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics

Search

Navigation